title: A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V.
abstract: Gerstmann-Sträussler-Scheinker disease (GSS) is a cerebral amyloidosis associated with mutations in the prion protein (PrP) gene (PRNP). The aim of this study was to characterize amyloid peptides purified from brain tissue of a patient with the A117V mutation who was Met/Val heterozygous at codon 129, Val(129) being in coupling phase with mutant Val117. The major peptide extracted from amyloid fibrils was a approximately 7-kDa PrP fragment. Sequence analysis and mass spectrometry showed that this fragment had ragged N and C termini, starting mainly at Gly88 and Gly90 and ending with Arg148, Glu152, or Asn153. Only Val was present at positions 117 and 129, indicating that the amyloid protein originated from mutant PrP molecules. In addition to the approximately 7-kDa peptides, the amyloid fraction contained N- and C-terminal PrP fragments corresponding to residues 23-41, 191-205, and 217-228. Fibrillogenesis in vitro with synthetic peptides corresponding to PrP fragments extracted from brain tissue showed that peptide PrP-(85-148) readily assembled into amyloid fibrils. Peptide PrP-(191-205) also formed fibrillary structures although with different morphology, whereas peptides PrP-(23-41) and PrP-(217-228) did not. These findings suggest that the processing of mutant PrP isoforms associated with Gerstmann-Sträussler-Scheinker disease may occur extracellularly. It is conceivable that full-length PrP and/or large PrP peptides are deposited in the extracellular compartment, partially degraded by proteases and further digested by tissue endopeptidases, originating a approximately 7-kDa protease-resistant core that is similar in patients with different mutations. Furthermore, the present data suggest that C-terminal fragments of PrP may participate in amyloid formation.
authors.affiliation: Istituto Nazionale Neurologico Carlo Besta, 20133 Milano, Italy. ftagliavini@istituto-besta.it
authors.forename: F
authors.initials: F
authors.lastname: Tagliavini
authors.forename: P M
authors.initials: PM
authors.lastname: Lievens
authors.forename: C
authors.initials: C
authors.lastname: Tranchant
authors.forename: J M
authors.initials: JM
authors.lastname: Warter
authors.forename: M
authors.initials: M
authors.lastname: Mohr
authors.forename: G
authors.initials: G
authors.lastname: Giaccone
authors.forename: F
authors.initials: F
authors.lastname: Perini
authors.forename: G
authors.initials: G
authors.lastname: Rossi
authors.forename: M
authors.initials: M
authors.lastname: Salmona
authors.forename: P
authors.initials: P
authors.lastname: Piccardo
authors.forename: B
authors.initials: B
authors.lastname: Ghetti
authors.forename: R C
authors.initials: RC
authors.lastname: Beavis
authors.forename: O
authors.initials: O
authors.lastname: Bugiani
authors.forename: B
authors.initials: B
authors.lastname: Frangione
authors.forename: F
authors.initials: F
authors.lastname: Prelli
mesh_terms: D000328:Adult; D000483:Alleles; D000682:Amyloid / Q000235:genetics*; D002540:Cerebral Cortex / Q000473:pathology; D016098:Gerstmann-Straussler-Scheinker Disease / Q000209:etiology* / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D008297:Male; D008715:Methionine / Q000235:genetics; D010446:Peptide Fragments / Q000302:isolation & purification*; D000072002:Prion Proteins; D011328:Prions / Q000302:isolation & purification / Q000472:pathogenicity*; D011498:Protein Precursors / Q000235:genetics*; D020539:Sequence Analysis, Protein; D013577:Syndrome; D014633:Valine / Q000235:genetics
chemical_list: D000682:Amyloid; C512656:PRNP protein, human; D010446:Peptide Fragments; D000072002:Prion Proteins; D011328:Prions; D011498:Protein Precursors; D008715:Methionine; D014633:Valine